Yang Lan, Liang Yuzhu, Li Riheng, Chen Yuan, Zhang Xia
Lan Yang, Department of Nutritional, Affiliated Hospital of Hebei University, Baoding 071000, Hebei, China.
Yuzhu Liang, Department of Nutritional, Affiliated Hospital of Hebei University, Baoding 071000, Hebei, China.
Pak J Med Sci. 2024 Nov;40(10):2344-2349. doi: 10.12669/pjms.40.10.9032.
To investigate the effects of probiotics combined with enteral nutrition therapy on intestinal flora, digestive tract symptoms and endogenous environment in patients with gastric cancer undergoing chemotherapy.
In this retrospective study, eighty patients with gastric cancer undergoing chemotherapy admitted to Affiliated Hospital of Hebei University from January 2021 to September 2023 were included and divided into two groups by random number table method: the enteral nutrition group and the probiotics combined enteral nutrition group (n=40 each group). The differences in the number of intestinal flora, nutritional indicators, immune function, endotoxin, D-lactic acid levels between the two groups, and the digestive tract symptoms of the two groups before and after treatment were compared and recorded.
The levels of serum total protein (TP), prealbumin (PAB), albumin (ALB) and transferrin (TF) in both groups were higher than those before treatment, and those in the probiotics combined with enteral nutrition group were higher than those in the enteral nutrition group (p< 0.05). The levels of immunoglobulin A (lgA), immunoglobulin M (lgM) and immunoglobulin G (lgG) in the two groups were lower than before treatment, and those in the probiotics combined with the enteral nutrition group were lower than those in the enteral nutrition group (p< 0.05).
Probiotics combined with enteral nutrition results in various benefits in the treatment of patients with gastric cancer undergoing chemotherapy, improving immunity, and reducing gastrointestinal symptoms.
探讨益生菌联合肠内营养疗法对胃癌化疗患者肠道菌群、消化道症状及内环境的影响。
本回顾性研究纳入2021年1月至2023年9月在河北大学附属医院接受化疗的80例胃癌患者,采用随机数字表法分为两组:肠内营养组和益生菌联合肠内营养组(每组n = 40)。比较并记录两组肠道菌群数量、营养指标、免疫功能、内毒素、D-乳酸水平的差异,以及两组治疗前后的消化道症状。
两组血清总蛋白(TP)、前白蛋白(PAB)、白蛋白(ALB)和转铁蛋白(TF)水平均高于治疗前,且益生菌联合肠内营养组高于肠内营养组(p < 0.05)。两组免疫球蛋白A(IgA)、免疫球蛋白M(IgM)和免疫球蛋白G(IgG)水平均低于治疗前,且益生菌联合肠内营养组低于肠内营养组(p < 0.05)。
益生菌联合肠内营养对胃癌化疗患者的治疗有多种益处,可提高免疫力,减轻胃肠道症状。